Vyne Therapeutics Inc (VYNE) is near the middle in its industry group according to InvestorsObserver. VYNE gets an overall rating of 42. That means it scores higher than 42 percent of stocks. Vyne Therapeutics Inc gets a 35 rank in the Biotechnology industry. Biotechnology is number 20 out of 148 industries.
VYNE has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on VYNE!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 42 means the stock is more attractive than 42 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Vyne Therapeutics Inc Stock Today?
Vyne Therapeutics Inc (VYNE) stock is trading at $2.91 as of 2:25 PM on Wednesday, Mar 27, a rise of $0.08, or 2.83% from the previous closing price of $2.83. The stock has traded between $2.80 and $3.08 so far today. Volume today is elevated. So far 220,090 shares have traded compared to average volume of 109,435 shares.
Click Here to get the full Stock Report for Vyne Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
